Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease

References

• Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol 2010;45:9–16.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 2008;43:1–17.
   PubMed Web of Science ®Google Scholar
• Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol 2010;45:571–83.
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182–205.
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1090–100.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008;57:1682–9.
   PubMed Web of Science ®Google Scholar
• Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536–41.
   PubMed Web of Science ®Google Scholar
• Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, Zheng XX, Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003;4:1102–10.
   PubMed Web of Science ®Google Scholar
• Sánchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003;4:1093–101.
   PubMed Web of Science ®Google Scholar
• Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007;318:1141-3.
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233–40.
   PubMed Web of Science ®Google Scholar
• Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006;18:349–56.
   PubMed Web of Science ®Google Scholar
• Yagi Y, Andoh A, Inatomi O, Tsujikawa T, Fujiyama Y. Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J Gastroenterol 2007;42:746–53.
   PubMedGoogle Scholar
• Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006;203:1685–91.
   PubMed Web of Science ®Google Scholar
• Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007;204:41–7.
   PubMed Web of Science ®Google Scholar
• Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006;116:1317–26.
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005;6:1245–52.
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol 2010. [Epub ahead of print].
   Google Scholar
• Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 2006;203:1413–18.
   PubMed Web of Science ®Google Scholar
• Wang Y, Meng J, Wang X, Liu S, Shu Q, Gao L, Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 2008;67:63–70.
   PubMed Web of Science ®Google Scholar
• Li X, Chen G, Li Y, Wang R, Wang L, Lin Z, Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clin Immunol 2010;134:169–77.
   PubMed Web of Science ®Google Scholar
• Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439–44.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–9.
   PubMed Web of Science ®Google Scholar
• Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004;172:7169–76.
   PubMed Web of Science ®Google Scholar
• Anderson AC, Lord GM, Dardalhon V, Lee DH, Sabatos-Peyton CA, Glimcher LH, T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur J Immunol 2010;40:859–66.
   PubMed Web of Science ®Google Scholar
• Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985–96.
   PubMed Web of Science ®Google Scholar
• Hastings WD, Anderson DE, Kassam N, Koguchi K, Greenfield EA, Kent SC, TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009;39:2492–501.
   PubMed Web of Science ®Google Scholar
• Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994;102:828–32.
   PubMed Web of Science ®Google Scholar
• Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991;254:279–82.
   PubMed Web of Science ®Google Scholar
• Allen JE, Maizels RM. Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997;18:387–92.
   PubMedGoogle Scholar
• Rook G. Th1- or Th2-cell commitment during infectious disease: an oversimplification? Trends Immunol 2001;22:481–2.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002;72:486–91.
   PubMed Web of Science ®Google Scholar
• Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol 2010;185:1383–92.
   PubMed Web of Science ®Google Scholar
• Noguchi A, Watanabe K, Narumi S, Yamagami H, Fujiwara Y, Higuchi K, The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J Gastroenterol 2007;42:947–56.
   PubMedGoogle Scholar
• Wada J, Kanwar YS. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 1997;272:6078–86.
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010;235:172–89.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shu Q, Gao L, Hou N, Zhao D, Liu X, Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 2010;137:288–95.
   PubMed Web of Science ®Google Scholar
• Du WT, Zhao HF, Xu JH, Gu DS, Xue F, Ge J, The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum Immunol 2009;70:398–402.
   PubMedGoogle Scholar